Protein Glutamine Gamma Glutamyltransferase 2 Market
Protein Glutamine Gamma Glutamyltransferase 2 Market Size, Share & Trends Analysis by Type (CAT?5571, ERW?1041E, ZED?1227, and Others), and By End-User (Hospital, Clinic, and Others), Forecast Period (2026-2035)
Industry Overview
Protein glutamine gamma glutamyltransferase 2 market is growing at a CAGR of 6.2% during the forecast Period (2026-2035). The Market focuses on the production and application of TG2 enzymes, primarily used in clinical diagnostics, research, and therapeutic development. The market is driven by increasing awareness and diagnosis of autoimmune and gastrointestinal disorders, expansion of biotechnology research, and technological advancements in enzyme products. Hospitals, clinics, and research laboratories constitute the primary end users. Growth is supported by rising investment in life sciences, improved laboratory infrastructure, and expanding applications in disease monitoring and experimental studies worldwide.
Market Dynamics
Rising Prevalence of Target Diseases and Clinical Research Demand
A primary driver of the Protein Glutamine Gamma Glutamyltransferase 2 (TG2) market is the increasing global incidence of diseases where TG2 plays a diagnostic or therapeutic role — notably celiac disease and related autoimmune or gastrointestinal conditions. TG2 is a critical enzyme in the pathophysiology of celiac disease, helping clinicians and researchers understand disease mechanisms, develop diagnostics, and evaluate treatment effects. As awareness and diagnosis rates of such conditions grow worldwide, demand for TG2 reagents and associated research tools has correspondingly increased. This clinical and research demand fuels market growth as laboratories, hospitals, and pharmaceutical companies prioritize TG2?related investigations and product use.
Expansion of Biotechnology and Life Sciences Research
The broader expansion of biotechnology R&D including genomic, proteomic, and drug discovery studies is another significant market driver. Protein Glutamine Gamma Glutamyltransferase 2 is used not only in disease research but as a biomarker and experimental tool in multiple life sciences applications. As pharmaceutical and academic research investments rise, especially in personalized medicine and enzyme?targeted therapeutics, the need for specialized enzymes like TG2 and related assay kits increases. This growth is supported by advancements in laboratory technologies and increasing funding for translational research, which collectively widen the use cases and commercial demand for TG2 products.
Technological Advancements and Product Innovation
Technological innovation within life sciences and diagnostics also drives this market. Improvements in enzyme formulation, stability, and application?specific variants allow TG2 products to be more effective, reliable, and easier to integrate into complex assay systems. Vendors are increasingly focusing on product differentiation such as higher purity preparations, tailored formats for specific research workflows, and compatibility with high?throughput platforms which attracts more end users across clinical and research settings. These innovations expand the market by reducing technical barriers and enabling wider adoption of TG2?related solutions in both established and emerging labs globally.
Market Segmentation
- Based on the type, the market is segmented into CAT?5571, ERW?1041E, ZED?1227, and Others.
- Based on the end-user, the market is segmented into Hospital, Clinic, and Others.
ZED?1227 Segment to Grow at a Considerable Market Share
The ZED?1227 segment is generally recognized as the largest and most influential product type within the global market. While individual revenue numbers by type are proprietary to paid market reports, industry analyses consistently list ZED?1227 alongside other major TG2 product types such as CAT?5571 and ERW?1041E, with ZED?1227 often showing the strongest adoption due to its advanced clinical relevance and commercial focus across key therapeutic areas.
ZED?1227 has gained significant attention in recent years because it is one of the most extensively studied inhibitors targeting the TG2 enzyme, particularly in the context of celiac disease and related gastrointestinal disorders. Its progression through clinical research and potential for broad therapeutic application has driven higher demand and larger market share compared with other types in the product lineup. This prominence reflects both stronger investment from developers and broader uptake in research and clinical environments.
As a result, when evaluating market leadership by product type within the Protein Glutamine Gamma Glutamyltransferase 2 landscape, which includes CAT?5571, ERW?1041E, ZED?1227, and others, ZED?1227 emerges as the single largest segment, contributing substantially to overall market value, growth, and visibility.
Hospital: A Key Segment in Market Growth
The hospital segment is projected to be the key growth driver in the Global Protein Glutamine Gamma Glutamyltransferase 2 market. Hospitals represent the largest and most consistent end-user base due to their extensive diagnostic and clinical research activities. Protein Glutamine Gamma Glutamyltransferase 2 (TG2) plays a crucial role in the diagnosis and monitoring of autoimmune diseases such as celiac disease, which require precise enzyme-based assays often conducted in hospital laboratories.
Hospitals are increasingly adopting advanced diagnostic tools and biomarkers to improve patient outcomes, streamline disease detection, and support translational research. Additionally, the expansion of hospital networks in emerging economies, coupled with rising healthcare expenditure, is driving higher procurement of specialized reagents like TG2. Hospitals also serve as hubs for clinical trials and collaborative research initiatives with pharmaceutical companies, further increasing the demand for TG2 products. The integration of high-throughput laboratories, automation technologies, and digital diagnostics in hospital settings ensures more frequent and reliable usage of TG2-based assays, solidifying this segment’s dominance. Overall, the hospital end-user segment benefits from both volume demand and strategic importance in research and diagnostics, making it the leading contributor to market growth in the coming decade.
Regional Outlook
The global protein glutamine gamma glutamyltransferase 2 market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US dominates the global protein glutamine gamma glutamyltransferase 2 market, holding a major share due to its advanced healthcare infrastructure, high adoption of cutting-edge diagnostic technologies, and robust research ecosystem. The country has a well-established network of hospitals, research institutions, and biotechnology companies that actively use TG2 for both clinical diagnostics and biomedical research. Increasing awareness and diagnosis of autoimmune diseases, particularly celiac disease, have further fueled demand for TG2-based assays and reagents. Additionally, funding for life sciences research, including government initiatives and private investments, supports continuous product development and innovation, ensuring that US laboratories and hospitals have ready access to high-quality TG2 products. The presence of key market players and manufacturers in North America also facilitates efficient distribution and technical support, encouraging widespread adoption across hospitals and research facilities. Moreover, regulatory support and faster approval pathways for diagnostic reagents allow new TG2 products to reach the market quickly, further consolidating the country’s leadership position. The combination of technological advancements, strong research activity, and a well-developed healthcare ecosystem positions the United States as the central hub driving global growth in the Protein Glutamine Gamma Glutamyltransferase 2 market.
Market Players Outlook
The major companies operating in the global protein glutamine gamma glutamyltransferase 2 market include AbbVie Inc., Bristol Myers Squibb Co., Merck KGaA, Novartis International AG, Roche Holding AG, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In July?2024, Clinical progress was reported for ZED1227, a transglutaminase?2 (TG2) inhibitor being studied to help manage celiac disease by blocking TG2?mediated intestinal damage alongside a gluten?free diet. This advancement highlighted the therapeutic relevance of TG2?targeted compounds in autoimmune disease research and their growing importance in the enzyme market
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global protein glutamine gamma glutamyltransferase 2 market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Analysis – Type | End-User ($ Million)
- Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Protein Glutamine Gamma Glutamyltransferase 2 Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Protein Glutamine Gamma Glutamyltransferase 2 Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Protein Glutamine Gamma Glutamyltransferase 2 Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Protein Glutamine Gamma Glutamyltransferase 2 Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Protein Glutamine Gamma Glutamyltransferase 2 Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Protein Glutamine Gamma Glutamyltransferase 2 Market Revenue and Share by Manufacturers
- Protein Glutamine Gamma Glutamyltransferase 2 Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- AbbVie Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Bristol Myers Squibb Company
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck KGaA
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Novartis International AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Roche Holding AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- AbbVie Inc.
- Key Company Analysis
- Global Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Analysis by Type ($ Million)
- CAT?5571
- ERW?1041E
- ZED?1227
- Others
- Global Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Analysis by End-User ($ Million)
- Hospital
- Clinic
- Others
- Regional Analysis
- North American Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Analysis – Type | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Analysis – Type | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Analysis – Type | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Protein Glutamine Gamma Glutamyltransferase 2 Market Sales Analysis – Type | End-User | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Advanced Enzyme Technologies Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ajinomoto Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Amano Enzyme Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BASF SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Beckman Coulter
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Catabasis Pharmaceuticals Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Creative BioMart
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dyadic International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lonza Group AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medifast
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nitta Gelatin Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ProCell
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Randox Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Roche Diagnostics
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sekisui Diagnostics
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sysmex Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zedira GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global CAT?5571 Protein Glutamine Gamma Glutamyltransferase 2 Market Research And Analysis By Region, 2025–2035 ($ Million)
3. Global ERW?1041E Protein Glutamine Gamma Glutamyltransferase 2 Market Research And Analysis By Region, 2025–2035 ($ Million)
4. Global ZED?1227 Protein Glutamine Gamma Glutamyltransferase 2 Market Research And Analysis By Region, 2025–2035 ($ Million)
5. Global Other Type Protein Glutamine Gamma Glutamyltransferase 2 Market Research And Analysis By Region, 2025–2035 ($ Million)
6. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by End-User, 2025–2035 ($ Million)
7. Global Protein Glutamine Gamma Glutamyltransferase 2 For Hospitals Market Research And Analysis By Region, 2025–2035 ($ Million)
8. Global Protein Glutamine Gamma Glutamyltransferase 2 For Clinic Market Research And Analysis By Region, 2025–2035 ($ Million)
9. Global Protein Glutamine Gamma Glutamyltransferase 2 For Other End User Market Research And Analysis By Region, 2025–2035 ($ Million)
10. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by Region, 2025–2035 ($ Million)
11. North American Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by Type, 2025–2035 ($ Million)
12. North American Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by End-User, 2025–2035 ($ Million)
13. European Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by Type, 2025–2035 ($ Million)
14. European Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by End-User, 2025–2035 ($ Million)
15. Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by Type, 2025–2035 ($ Million)
16. Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by End-User, 2025–2035 ($ Million)
17. Rest of the World Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Rest of the World Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by Type, 2025–2035 ($ Million)
19. Rest of the World Protein Glutamine Gamma Glutamyltransferase 2 Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Type, 2025 vs 2035 (%)
2. Global CAT?5571 Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Region, 2025 vs 2035 (%)
3. Global ERW?1041E Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Region, 2025 vs 2035 (%)
4. Global ZED?1227 Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Region, 2025 vs 2035 (%)
5. Global Other Type Protein Glutamine Gamma Glutamyltransferase 2 Market Share by Region, 2025 vs 2035 (%)
6. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Share by End-User, 2025 vs 2035 (%)
7. Global Protein Glutamine Gamma Glutamyltransferase 2 For Hospitals Market Share by Region, 2025 vs 2035 (%)
8. Global Protein Glutamine Gamma Glutamyltransferase 2 For Clinics Market Share by Region, 2025 vs 2035 (%)
9. Global Protein Glutamine Gamma Glutamyltransferase 2 For Other End Users Market Share by Region, 2025 vs 2035 (%)
10. Global Protein Glutamine Gamma Glutamyltransferase 2 Market Share By Region, 2025 Vs 2035 (%)
11. US Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
12. Canada Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
13. UK Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
14. France Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
15. Germany Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
16. Italy Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
17. Spain Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
18. Russia Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
19. Rest of Europe Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
20. India Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
21. China Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
22. Japan Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
23. South Korea Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
24. Australia and New Zealand Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
25. ASEAN Economies Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
26. Rest of Asia-Pacific Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
27. Latin America Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
28. Middle East and Africa Protein Glutamine Gamma Glutamyltransferase 2 Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
